Stock price performance of Perrigo Company is analyzed for various periods using several stock trading signals. The stock price have dropped -12.64% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -15.07% . Looking at the past 52 week period, the stock price is down -45.8% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of Perrigo Company has a negative value of -34.94 compared to overall market performance. Company shares have received an average consensus rating of Hold for the current week The stock has recorded a 20-day Moving Average of 7.16% and the 50-Day Moving Average is 11.22%.The 200 Day SMA reached 19.08%
Perrigo Company plc is having a Relative Strength Index of 49 which indicates the stock is not yet over sold or over bought based on the technical indicators. Stocks of Perrigo Company (NYSE:PRGO) rallied by 5.53% during the past week but lost 8.52% on a 4-week basis. The company has outperformed the S&P 500 by 5.41% in the past week but underperformed the index by 9.33% in the last 4 weeks.
Company has reported several Insider transactions to the SEC, on Nov 28, 2016, Judy L Brown (EVP, Business Ops & CFO) sold 2,097 shares at 89.44 per share price.On Nov 23, 2016, Todd W Kingma (Executive VP, General Counsel) sold 750 shares at 88.68 per share price.On Nov 21, 2016, Geoffrey M. Parker (director) purchased 2,500 shares at 88.75 per share price.
Perrigo Company plc Ordinary Shares Last issued its quarterly earnings results on Nov 10, 2016. The company reported $1.65 EPS for the quarter, beating the analyst consensus estimate by $ 0.09. Analyst had a consensus of $1.56. The company had revenue of $1354.90 million for the quarter, compared to analysts expectations of $1279.65 million. The companys revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.76 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Perrigo Company plc Ordinary Shares was Reiterated by Jefferies on Jan 23, 2017 to Hold, Lowers Price Target to $ 70 from a previous price target of $84 .Perrigo Company plc Ordinary Shares was Reiterated by RBC Capital Mkts on Jan 17, 2017 to Sector Perform, Lowers Price Target to $ 85 from a previous price target of $92 .Perrigo Company plc Ordinary Shares was Upgraded by BofA/Merrill to Neutral on Nov 11, 2016.
Perrigo Company (NYSE:PRGO) stock ended Friday session in the red zone in a volatile trading. The stock closed down 0.43 points or 0.55% at $77.99 with 1,972,203 shares getting traded. Post opening the session at $78.91, the shares hit an intraday low of $77.46 and an intraday high of $79.05 and the price was in this range throughout the day. The company has a market cap of $11,182 million and the number of outstanding shares has been calculated to be 143,374,430 shares. The 52-week high of Perrigo Company (NYSE:PRGO) is $147.58 and the 52-week low is $71.84.
Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.